Corrina de Ridder

Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy

Eline A. M. Ruigrok, Nicole van Vliet, Simone U. Dalm et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 101 citations · Full text

Medicine, Oncology, Pharmacology +17

In Vivo Stabilization of a Gastrin-Releasing Peptide Receptor Antagonist Enhances PET Imaging and Radionuclide Therapy of Prostate Cancer in Preclinical Studies

Kristell L.S. Chatalic, Mark Konijnenberg, Julie Nonnekens et al. · Theranostics · 2015 · 69 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Understanding taxanes in prostate cancer; importance of intratumoral drug accumulation

Ellen de Morrée, Robert J. van Soest, Ashraf Aghai et al. · The Prostate · 2016 · 38 citations

Medicine, Oncology, Pharmacology +17

First preclinical evaluation of [225Ac]Ac-DOTA-JR11 and comparison with [177Lu]Lu-DOTA-JR11, alpha versus beta radionuclide therapy of NETs

Maryana Handula, Savanne Beekman, Mark Konijnenberg et al. · EJNMMI Radiopharmacy and Chemistry · 2023 · 21 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

[212Pb]Pb-eSOMA-01: A Promising Radioligand for Targeted Alpha Therapy of Neuroendocrine Tumors

Dylan Chapeau, Sofia Koustoulidou, Maryana Handula et al. · Pharmaceuticals · 2023 · 20 citations · Full text

Medicine, Nuclear Medicine, Oncology +17